Navigation Links
Octapharma AG Announces Second Quarter 2009 Results and Mid Term Outlook of the Market
Date:10/2/2009

LACHEN, Switzerland, Oct. 2 /PRNewswire/ -- Through June 2009, Octapharma AG realized a record turnover of 536 M euro, compared to 422 M euro as of year-to-date June 2008, an increase of 27%.

(Photo: http://www.newscom.com/cgi-bin/prnh/20091002/NY86257)

The cost of sales increased proportionally more than the turnover, decreasing gross margin from 46.4% to 43.3%, primarily due to increased plasma costs.

Due to increased efficacy in other areas, Octapharma reached a satisfactory level in its operating income through June 2009 (earnings before interest and taxes) of 173 M euro (32.3% margin), compared with 141 M euro (33.4% margin) in the same period of 2008.

Plasma Protein Industry's Outlook for the Second Half 2009 and 2010

In the area of plasma collection, the fact that plasma collection centers are closing on Saturdays and that the remaining independent plasma suppliers offer discounts confirms that there is an oversupply.

Declining prices in government and hospital tenders worldwide also point in this direction.

In spite of a continuous growth of 5% - 6% in the IVIG market we therefore expect monthly sales to stay at the present level with higher quantities the remaining part of 2009. 2010 will remain flat compared to 2009, again with higher unit sales.

A high pressure in many countries on the reimbursement structure will further contribute to the negative trend. However, the patients can on this basis experience a more stable supply of products with fewer interruptions. Octapharma intends to overcome the present trend by the launch of new products.

Octapharma AG

Headquartered in Lachen, Switzerland, Octapharma is the third largest plasma prod
'/>"/>

SOURCE Octapharma AG
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. First Pharmaceutical Company Comes to Hoboken, NJ: Swiss-Based Octapharma to Move U.S. Headquarters to SJP Properties Waterfront Corporate Center II
2. Pillar Capital Announces Acquisition of Medico Labs Assets
3. Cyberonics Announces Epilepsy Technology Collaborations
4. Bionovo Announces Pricing of Securities Offering
5. Winner Medical Announces Two-for-One Reverse Stock Split
6. DST Systems, Inc. Announces Exchange Transaction Involving 4.125% Series A Convertible Senior Debentures
7. Healthcare Realty Trust Announces New $550 Million Unsecured Revolving Credit Facility
8. Lumetra Announces Sale of Subsidiary IntegriGuard
9. UCSF Announces Expanded BreastCancerTrials.org Website
10. DSS Research Announces Senior Health Risk Assessment (SrHRA)(TM)
11. US Farms, Inc. Announces Distribution Partnership With Natures Best
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 02, 2014 Nanomedicine is essentially ... diagnosing, treating and/or prevention of diseases and infections. ... cardiovascular, neurological, and oncology diseases. , Nanomedicine ... to various nanoparticles, their medical usages, and their ... considerable scope for research in this domain, and ...
(Date:9/2/2014)... September 02, 2014 West Hollywood ... complimentary consultations for Invisalign. This special offer includes a ... smiles to determine their candidacy for the procedure and ... Qualified patients may also be eligible for the Summer ... remainder of the month of August, patients who choose ...
(Date:9/2/2014)... HealthDay Reporter , MONDAY, Sept. 1, 2014 (HealthDay ... boost their heart health, cutting down on carbohydrates may work ... In a small clinical trial of obese adults, researchers found ... weight over a year than those who followed a low-fat ... and triglyceride levels, the research team reports in the Sept. ...
(Date:9/2/2014)... New York (PRWEB) September 02, 2014 ... announces that Class Counsel has filed an ... service awards in the class action litigation brought ... Waichman LLP, the Court-Appointed Class Counsel in this ... & Bernstein, LLP; Audet & Partners, LLP; Levin ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 A little ... everyone. But sometimes the onset of irritability, sadness, or ... reports the September 2014 Harvard Health Letter. ... to everyday stresses. If they occur for long periods, ... an indication to seek help," says Dr. Nancy Donovan, ...
Breaking Medicine News(10 mins):Health News:Nanomedicine Market: An Overview of Growth Factors and Future Prospects by Transparency Market Research 2Health News:Nanomedicine Market: An Overview of Growth Factors and Future Prospects by Transparency Market Research 3Health News:West Hollywood Cosmetic Dentist, Dr. Poneh Ghasri, Now Offers Complimentary Consultations for Invisalign 2Health News:Low-Carb Beats Low-Fat for Weight Loss, Heart Health: Study 2Health News:Low-Carb Beats Low-Fat for Weight Loss, Heart Health: Study 3Health News:A Proposed Order Has Been Submitted in A Class Action Law Suit Brought Over Flushmate Toilets, Parker Waichman Announces 2Health News:A Proposed Order Has Been Submitted in A Class Action Law Suit Brought Over Flushmate Toilets, Parker Waichman Announces 3Health News:When a Mood Swing Signals Trouble, From the September 2014 Harvard Health Letter 2
... CHICAGO, Oct. 20 A Chicago company that has been revolutionizing ... joined up with Harvard Common Press, the publisher of The ... guide for new moms. This package of three great resources ... download at www.thebabycd.com. , Moms can now get The Baby ...
... Sangamo BioSciences, Inc. (Nasdaq: SGMO ... Phase 2 clinical data from its ZFP Therapeutic(TM) program ... (DN) at the Society for Neuroscience Annual Meeting held ... 2 clinical trial demonstrated a direct neuroregenerative effect of ...
... today,s challenging times, Ankhasha,s Temple of the Western Gate is ... and development. Ankhasha Amenti has opened the Temple in response ... and spiritual renewal in this stressful world. , The ... 34 million Americans claim no religion - up from 14 ...
... , WASHINGTON, Oct. 20 In testimony to a ... offered recommendations on ways to better meet the needs ... with special requirements. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090108/RedCrossLOGO ) , ... testified Tuesday as to how the Red Cross is ...
... , CHICAGO, Oct. 20 After a decade marked by ... is on the rise and is expected to continue increasing ... released today by Aon Corporation in ... Management . , (Logo: http://www.newscom.com/cgi-bin/prnh/20041215/CGW049LOGO ) ...
... liver disease who drink three or more cups of coffee ... progression than non-coffee drinkers according to a new study led ... (NCI). The study found that patients with hepatitis C-related ... disease treatment benefited from increased coffee intake. An effect ...
Cached Medicine News:Health News:New Moms to Receive FREE STIMULUS PACKAGE Worth More Than $50 2Health News:Sangamo BioSciences Announces Presentation of Top-Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeting 2Health News:Sangamo BioSciences Announces Presentation of Top-Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeting 3Health News:Sangamo BioSciences Announces Presentation of Top-Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeting 4Health News:Sangamo BioSciences Announces Presentation of Top-Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeting 5Health News:Sangamo BioSciences Announces Presentation of Top-Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeting 6Health News:Sangamo BioSciences Announces Presentation of Top-Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeting 7Health News:Sangamo BioSciences Announces Presentation of Top-Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeting 8Health News:Recession, Decline of Organized Religion Drive People to Find New Answers 2Health News:Red Cross Strives to Help Disaster's Vulnerable Population 2Health News:Red Cross Strives to Help Disaster's Vulnerable Population 3Health News:Frequency of Hospital Professional Liability Claims Increasing After Years of Declines, Says Aon and ASHRM Study 2Health News:Frequency of Hospital Professional Liability Claims Increasing After Years of Declines, Says Aon and ASHRM Study 3Health News:Frequency of Hospital Professional Liability Claims Increasing After Years of Declines, Says Aon and ASHRM Study 4Health News:Drinking coffee slows progression of liver disease in chronic hepatitis C sufferers 2
(Date:9/2/2014)... 2014  VentiRx Pharmaceuticals, Inc., a clinical ... and commercialization of novel Toll-like receptor 8 ... Food and Drug Administration (FDA) has granted ... motolimod (VTX-2337) when administered in combination with ... of women with ovarian cancer whose disease ...
(Date:9/2/2014)...   Intrexon Corporation (NYSE: XON ... it has entered into an Exclusive Channel Collaboration (ECC) ... (EURONEXT: SAN and NYSE: SNY ) to ... of its marketed Active Pharmaceutical Ingredients (APIs) through Sanofi,s ... This collaboration will leverage Intrexon,s proprietary technology suite plus ...
(Date:9/2/2014)... , Sept. 2, 2014   Veracyte, Inc. (Nasdaq: ... Anderson , president and chief executive officer, will present in ... Healthcare Unplugged Conference 2014 on Monday, September 8, 2014 at ... The live audio webcast and subsequent replay may ... Please connect to the website at least 15 minutes prior ...
Breaking Medicine Technology:VentiRx Pharmaceuticals Announces Fast Track Designation Granted for Motolimod (VTX-2337), a Novel Immunotherapy for Women with Ovarian Cancer 2VentiRx Pharmaceuticals Announces Fast Track Designation Granted for Motolimod (VTX-2337), a Novel Immunotherapy for Women with Ovarian Cancer 3Intrexon Announces Exclusive Channel Collaboration with Sanofi to Optimize Production for a Specific Family of Active Pharmaceutical Ingredients 2Intrexon Announces Exclusive Channel Collaboration with Sanofi to Optimize Production for a Specific Family of Active Pharmaceutical Ingredients 3Veracyte to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2014 2
... YORK, Sept. 1, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p0559262/Global-CRO-Market-Quantitative-Assessment.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development This ... globally, by phase and market type, R&D ...
... This evening, Novo Nordisk awarded sponsorships totaling ... that educate people living with type 2 diabetes on ... risk of long-term diabetes related complications. The sponsorships are ... aims to promote enduring, sustainable change for people living ...
Cached Medicine Technology:Global CRO Market: Quantitative Assessment 2Global CRO Market: Quantitative Assessment 3Novo Nordisk Partners with Minneapolis Community Groups to Support Diabetes Education Programs 2
Megakwik Malaria ( P.falciparum ) Card Test...
Malaria ( P. Falciparum ) Whole Blood Strip / Cassette...
The KAT-Quick Malaria test was designed for the diagnosis of Malaria, in laboratories, the home and for medical kits when travelling into malaria regions....
DiaMed OptiMAL-IT is an immuno-chromatographic test, using monoclonal antibodies against the metabolic enzyme pLDH (parasite lactate dehydrogenase) of Plasmodium spp. These Mabs are classified in t...
Medicine Products: